Mixed vascular occlusion in a patient with interferon-associated retinopathy

Case Reports in Ophthalmology

Volumn 2, Issue 1, 2011, Pages 23-29

  Bajaire, Boris J ^a   Paipilla, Diego F ^a   Arrieta, Cesar E ^b   Oudovitchenko, Elena ^c  

^a San Martin University   (Colombia)

^b UNIVERSIDAD NACIONAL DE SAN MARTÍN   (Argentina)

^c Plastic and Reconstructive Surgery Department of the Hospital Simón Bolivar   (Colombia)

Author keywords

Hepatitis C virus; Interferon associated retinopathy; Mixed vascular occlusion

Indexed keywords

BEVACIZUMAB; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; FLUORESCENCE ANGIOGRAPHY; HEPATITIS C; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA BLOOD VESSEL OCCLUSION; RETINA DETACHMENT; RETINA ISCHEMIA; RETINOPATHY; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION; VITRECTOMY;

EID: 79957594895     PISSN: None     EISSN: 16632699     Source Type: Journal    
DOI: 10.1159/000323942     Document Type: Article

References (13)

1. WHO: Hepatitis C: Global prevalence. Wkly Epidemiol Rec 2002;77:6.
2. Okuse C, Yotsuyanagi H, Nagase Y, et al: Risk factors for retinopathy as associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C. J Gastroenterol 2006;12:3756-3759. (Pubitemid 43950955)
3. Cuthbertson FM, Davies M, McKibbin M: Is screening for interferon retinopathy in hepatitis C justified? Br J Ophthalmol 2004;88:1518-1520. (Pubitemid 39573588)
4. Jain K, Lam WC, Waheeb S, Thai Q, Heathcote J: Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin. Br J Ophthalmol 2001;85:1171-1173. (Pubitemid 32929539)
5. Sène D, Touitou V, Bodaghi B, et al: Intraocular complications of INF-a and ribavirin therapy in patients with chronic viral hepatitis C. World J Gastroenterol 2007;13:3137-3140. (Pubitemid 47045476)
6. Mantel I, Konstantinidis L, Zografos L: Interferon-associated retinopathy. A Case Report. Klin Monatsbl Augenheilkd 2007;224:350-352.
7. Andrade R, González J, Vázquez L, et al: Vascular ophthalmological side effects associated with antiviral therapy for chronic hepatitis C are related to vascular endothelial growth factor levels. Antivir Ther 2006;11:491-498. (Pubitemid 44024857)
8. Schmidt S, Pleyer U: Interferon-a assoziierte Retinopathie bei Patienten mit chronischer Hepatitis C. Klin Monatsbl Augenheilkd 2005;22:915-918. (Pubitemid 41806696)
9. Stoffelns B: Interferon löst okuläre Ischämien aus. Fallserie und Literaturüberblick. Klin Monatsbl Augenheilkd 2006;223:467-371.
10. Francis J, Ho I, Yannuzzi L: Vitreous hemorrhage associated with interferon-a therapy for chronic hepatitis C. Retinal Cases and Brief Reports 2008;2:262-263.
11. Martínez H, Pulido J, Haupert C, et al: Interferon-a associated retinopathy. Retinal Cases and Brief Reports 2009;3:24-26.
12. Gunther J, Altaweel M: Bevacizumab (Avastin) for the treatment of ocular disease. Surv Ophthalmol 2009;54:372-400.
13. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM: Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994;25:1794-1798. (Pubitemid 24274974)